“I’ve never been more hopeful about the possibility of improving the survival rate for this disease,” said researcher Sana Karam, who noted the animal study could change the way doctors treat the condition in the “near future.”
Late-stage trials suggest Lilly’s tirzepatide, sold under Mounjaro, could be a more effective obesity drug that Ozempic or Wegovy, and the company expects a regulatory decision by the end of the year.
Early findings suggest the drug, which is already approved for MS symptoms, could slash the risk of people with no symptoms but who have signs of nerve damage on MRI scans.
GSK said Bellus’ experimental cough medicine could help treat millions of people with untreatable chronic coughs and had “significant sales potential” if approved.
The 5th Circuit partially blocked an order from a Trump-appointed judge that would have thrown access to mifepristone into doubt at the end of the week.
The test, capable of detecting Parkinson’s before the onset of symptoms, “launches a new, biological era in Parkinson’s research” and could pave the way for a cure, said researcher Kenneth Marek.